With the aging population,the burden of diseases such as atrial fibrillation and venous thrombosis is gradually increasing.Anticoagulant therapy has a positive significance in preventing ischemic stroke,pulmonary embolism,and other related conditions in these patients.However,anticoagulant therapy can have the opposite effect on diseases caused by intracranial hemorrhage,such as falls in the elderly,cerebrovascular accidents,and car accidents.It is still difficult to determine whether and when to restart anticoagulation after cerebral hemorrhage.Although most studies have shown that restarting anticoagulant therapy can reduce stroke risk without significantly increasing bleeding risk,they are mostly based on observational studies,so more high-quality research is needed to guide clinical decision-making.This article reviews the research progress on restart anticoagulation,aiming to provide some assistance for clinical applications.
维普
万方数据